By Fineline Cube 
Shenzhen Concemed Medical Technology Co., Ltd., a China-based endoscope specialist, has reportedly secured “hundreds of millions” of renminbi in a Series A+ financing round. The funding was led by a prominent industry investor, with participation from Alwin Capital and existing shareholder IDG Capital.
Funding Utilization
The proceeds from this financing round will be allocated to enhance brand development and accelerate the commercialization of Concemed Medtech’s flexible endoscopy product line both domestically and internationally. Additionally, the funds will support the advancement of R&D across multiple product pipelines.
Company Background
Founded in 2022, Concemed Medtech has established itself as an innovator in the medical technology sector with its comprehensive AI + V1000 System + Optical Zoom Endoscopy solution. The company’s V1000 system stands out with its first-in-class one-click auto-focus feature, which significantly enhances diagnostic efficiency. The system’s multi-mode optical imaging capabilities are designed to meet a wide range of clinical needs, from initial screening to treatment, providing healthcare professionals with versatile tools to improve patient outcomes.-Fineline Info & Tech